22022059

Source:http://linkedlifedata.com/resource/pubmed/id/22022059

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0013072, umls-concept:C0025266, umls-concept:C0034656, umls-concept:C0332240, umls-concept:C1515075
pubmed:issue	3
pubmed:dateCreated	2011-10-24
pubmed:abstractText	There is insufficient scientific data on the medical management options for idiopathic oligoasthenoteratospermia (iOATs). We conducted a double blind, randomized, placebo-controlled trial to assess the efficacy and safety of the herbo-mineral supplement, Addyzoa(®), in infertile men with iOATs. We also evaluated its effect on semen reactive oxygen species (ROS) levels, total antioxidant capacity (TAC) and DNA fragmentation index.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8510441
pubmed:status	PubMed-not-MEDLINE
pubmed:month	Jul
pubmed:issn	1998-3824
pubmed:author	pubmed-author:DadaRimaR, pubmed-author:KumarRajeevR, pubmed-author:SaxenaVaibhavV, pubmed-author:ShamsiMonis BilalMB, pubmed-author:VenkateshSS
pubmed:issnType	Electronic
pubmed:volume	27
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	357-62
pubmed:year	2011
pubmed:articleTitle	Herbo-mineral supplementation in men with idiopathic oligoasthenoteratospermia : A double blind randomized placebo-controlled trial.
pubmed:affiliation	Department of Urology, All India Institute of Medical Sciences, New Delhi, India.
pubmed:publicationType	Journal Article